Skip to content
Search

Latest Stories

DHSC releases second list of January price concessions

pharmacy.biz Staff
By pharmacy.biz StaffJan 23, 2020
pharmacy.biz Staff
See Full Bio

The Department of Health and Socialcare (DHSC) today published its second list of price concessions for January 2020.

The announcement, revealed by the PSNC, follows the first announcement on January 15.

The latest list (below) covers 32 drugs.

Amiloride 5mg tablets28£22.38
Co-careldopa 25mg/100mg tablets100£10.69
Diclofenac sodium 75mg modified-release tablets56£15.00
Fluoxetine 10mg capsules30£47.50
Hydroxyzine 10mg tablets84£2.12
Hydroxyzine 25mg tablets28£1.09
Irbesartan 75mg tablets28£2.80
Irbesartan 300mg tablets28£5.53
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£4.99
Lamotrigine 25mg dispersible tablets sugar free56£9.71
Levetiracetam 250mg tablets60£3.60
Lymecycline 408mg capsules28£5.70
Meloxicam 7.5mg tablets30£2.80
Meloxicam 15mg tablets30£5.60
Memantine 10mg tablets28£3.20
Memantine 20mg tablets28£8.05
Mirtazapine 15mg tablets28£2.10
Mirtazapine 30mg tablets28£2.20
Mirtazapine 45mg tablets28£2.40
Nefopam 30mg tablets90£14.96
Nitrazepam 5mg tablets28£2.70
Nitrofurantoin 50mg tablets28£13.27
Nitrofurantoin 100mg tablets28£9.32
Oxytetracycline 250mg tablets28£4.93
Ranitidine 300mg tablets30£4.80
Rivastigmine 3mg capsules28£4.29
Sulpiride 200mg tablets30£6.48
Tolterodine 2mg tablets56£2.62
Trihexyphenidyl 2mg tablets84£7.95
Venlafaxine 37.5mg tablets56£7.90
Venlafaxine 75mg tablets56£14.50
price concessions

Related News

Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA
Features

UK risks losing millions in NHS savings without stronger support for generics - BGMA

Pharmacist Support calls for birthday donations to meet rising demand for mental health services
News

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Prostate cancer: At-home saliva test could save NHS £500 million annually
News

Prostate cancer: Spit test better than blood test in spotting men at highest risk

RPS launches innovative new learning resources for members
News

RPS launches new learning resources to boost career development for members

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine, survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc